WallStSmart

Diversified Healthcare Trust (DHC)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 675% more annual revenue ($11.77B vs $1.52B). WELL leads profitability with a 12.0% profit margin vs -21.1%. DHC appears more attractively valued with a PEG of 1.89. WELL earns a higher WallStSmart Score of 57/100 (C).

DHC

Hold

39

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 6.3Quality: 5.5
Piotroski: 5/9Altman Z: -0.24

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 7.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DHCUndervalued (+89.5%)

Margin of Safety

+89.5%

Fair Value

$60.18

Current Price

$8.53

$51.65 discount

UndervaluedFair: $60.18Overvalued
WELLSignificantly Overvalued (-78.3%)

Margin of Safety

-78.3%

Fair Value

$116.05

Current Price

$200.84

$84.79 premium

UndervaluedFair: $116.05Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DHC1 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
157.9%10/10

Earnings expanding 157.9% YoY

Market CapQuality
$137.90B9/10

Large-cap with strong market position

Areas to Watch

DHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.894/10

Expensive relative to growth rate

Debt/EquityHealth
1.493/10

Elevated debt levels

Return on EquityProfitability
-19.8%2/10

ROE of -19.8% — below average capital efficiency

Revenue GrowthGrowth
-5.3%2/10

Revenue declined 5.3%

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
94.4x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DHC

The strongest argument for DHC centers on Price/Book.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : DHC

The primary concerns for DHC are PEG Ratio, Debt/Equity, Return on Equity.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 94.4x leaves little room for execution misses.

Key Dynamics to Monitor

DHC profiles as a turnaround stock while WELL is a growth play — different risk/reward profiles.

DHC carries more volatility with a beta of 2.32 — expect wider price swings.

WELL is growing revenue faster at 38.3% — sustainability is the question.

WELL generates stronger free cash flow (282M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 39/100) and 38.3% revenue growth. DHC offers better value entry with a 89.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diversified Healthcare Trust

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

DHC is a real estate investment trust, or REIT, that owns medical offices and life science properties, senior communities and wellness centers throughout the United States. The company is headquartered in Newton, MA.

Visit Website →

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?